250 related articles for article (PubMed ID: 33819437)
21. Dysproteinemias and Glomerular Disease.
Leung N; Drosou ME; Nasr SH
Clin J Am Soc Nephrol; 2018 Jan; 13(1):128-139. PubMed ID: 29114004
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.
Ciocchini M; Arbelbide J; Musso CG
Int Urol Nephrol; 2017 Dec; 49(12):2171-2175. PubMed ID: 28425076
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment.
Karam S; Haidous M; Dalle IA; Dendooven A; Moukalled N; Van Craenenbroeck A; Bazarbachi A; Sprangers B
Crit Rev Oncol Hematol; 2023 Mar; 183():103926. PubMed ID: 36736510
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal gammopathy-associated proliferative glomerulonephritis.
Sethi S; Rajkumar SV
Mayo Clin Proc; 2013 Nov; 88(11):1284-93. PubMed ID: 24182705
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal gammopathy of renal significance: Early diagnosis is key.
Alonso-Titos J; Martínez-Esteban MD; López V; León M; Martin-Reyes G; Ruiz-Esteban P; Hernández D
Nefrologia (Engl Ed); 2021; 41(5):502-513. PubMed ID: 36165133
[TBL] [Abstract][Full Text] [Related]
26. Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone.
Nasr SH; Larsen CP; Sirac C; Theis JD; Domenger C; Chauvet S; Javaugue V; Hogan JJ; Said SM; Dasari S; Vrana JA; McPhail ED; Cornell LD; Vilaine E; Massy ZA; Boffa JJ; Buob D; Toussaint S; Guincestre T; Touchard G; D'Agati VD; Leung N; Bridoux F
Kidney Int; 2020 Mar; 97(3):589-601. PubMed ID: 32001067
[TBL] [Abstract][Full Text] [Related]
27. Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report.
Hirashio S; Satoh A; Arima T; Mandai K; Awaya T; Oshima K; Hara S; Masaki T
BMC Nephrol; 2018 May; 19(1):108. PubMed ID: 29724182
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic characteristics and prognostic analysis of monoclonal gammopathy of renal significance (MGRS) in patients with IgM monoclonal gammopathy: a case series.
Liu J; Liang D; Liang S; Xu F; Huang X; Jiang S; Hou J
Sci Rep; 2022 Oct; 12(1):16994. PubMed ID: 36216844
[TBL] [Abstract][Full Text] [Related]
29. Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance.
Sprangers B; Hegenbart U; Wetzels JFM
Transplantation; 2023 May; 107(5):1056-1068. PubMed ID: 36584374
[TBL] [Abstract][Full Text] [Related]
30. DNAJB9-positive monotypic fibrillary glomerulonephritis is not associated with monoclonal gammopathy in the vast majority of patients.
Said SM; Leung N; Alexander MP; Cornell LD; Fidler ME; Grande JP; Herrera LH; Sethi S; Zhang P; Nasr SH
Kidney Int; 2020 Aug; 98(2):498-504. PubMed ID: 32622524
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological characteristics of patients with paraproteinemia and renal damage.
Tang X; Wan F; Yu J; Li X; Yang R; Zhu B
Eur J Med Res; 2021 Jul; 26(1):68. PubMed ID: 34217367
[TBL] [Abstract][Full Text] [Related]
32. An update to the pathogenesis for monoclonal gammopathy of renal significance.
Zuo C; Zhu Y; Xu G
Ann Hematol; 2020 Apr; 99(4):703-714. PubMed ID: 32103323
[TBL] [Abstract][Full Text] [Related]
33. Lambda light chain-induced monoclonal gammopathy of renal significance, manifesting with Fanconi Syndrome and osteomalacia.
Gutiérrez-Peredo GB; Filho JCBO; Montaño-Castellón I; Gutiérrez-Peredo AJ; Crusoé EQ; Gusmao-Flores D
BMC Nephrol; 2022 Aug; 23(1):278. PubMed ID: 35945525
[TBL] [Abstract][Full Text] [Related]
34. Updates in Plasma Cell Dyscrasias and Related Monoclonal Immunoglobulin-Mediated Renal Disease.
Midha S; Nadeem O; Selamet U
Semin Nephrol; 2022 Nov; 42(6):151352. PubMed ID: 37257390
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.
Leung N; Bridoux F; Hutchison CA; Nasr SH; Cockwell P; Fermand JP; Dispenzieri A; Song KW; Kyle RA;
Blood; 2012 Nov; 120(22):4292-5. PubMed ID: 23047823
[TBL] [Abstract][Full Text] [Related]
36. Pathophysiology and management of monoclonal gammopathy of renal significance.
Jain A; Haynes R; Kothari J; Khera A; Soares M; Ramasamy K
Blood Adv; 2019 Aug; 3(15):2409-2423. PubMed ID: 31409583
[TBL] [Abstract][Full Text] [Related]
37. [Monoclonal gammapathy of renal significance (MGRS) at the current state: terminology, diagnosis and treatment].
Lysenko Kozlovskaya LV; Rameev VV; Androsova TV
Ter Arkh; 2020 Jul; 92(6):15-22. PubMed ID: 33346488
[TBL] [Abstract][Full Text] [Related]
38. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance].
Li C; Wen YB; Li H; Su W; Li J; Cai JF; Chen LM; Li XM; Li XW
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(30):2344-2348. PubMed ID: 28822451
[No Abstract] [Full Text] [Related]
39. Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China.
Yu XJ; Zhang X; Li DY; Wang SX; Zhou FD; Zhao MH
Nephrology (Carlton); 2020 Mar; 25(3):202-211. PubMed ID: 31301197
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]